IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Broadfin Capital, LLC

Q4 2013 Holdings

Filed 2014-02-14 | 60 holdings | $51.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2014-02-28) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Anacor Pharmaceuticals IncCOM032420101$25.5K1,517,2310.0%
Tetraphase Pharmaceuticals ICOM88165N105$29.7K2,193,3280.1%
Flamel Technologies SASPONSORED ADR338488109$30.3K3,767,9110.1%
Horizon Pharma IncCOM44047T109$32.4K4,257,4690.1%
Novadaq Technologies IncCOM66987G102$32.5K1,969,6340.1%
Teva Pharmaceutical Inds LTD(TEVA)ADR881624209$33.7K841,7360.1%
Lannet IncCOM516012101$44.4K1,339,9450.1%
Depomed IncCOM249908104$50.2K4,744,7720.1%
Atricure Inc(ATRC)COM04963C209$8.2M437,49515.8%
Angiodynamics Inc(ANGO)COM03475V101$42.8M2,497,04982.8%
PreviousPage 2 of 2